Stromal cell-derived factor 4 (SDF4) responds to anticancer drugs by activating CEBPD within CAFs, establishing a favorable environment for angiogenesis in tumor cells and facilitating distant metastasis. This evidence concerns the gene SDF4 and neoplasm.